Fighting the spread of viruses: Producing cheap vaccines, quickly

(Medical Xpress)—Immunising people with vaccines that are quick and inexpensive to produce is the answer to preventing large-scale spread of infectious disease, Professor Anton Middelberg from UQ's Australian Institute for Bioengineering and Nanotechnology says.

Using modern molecular and bioprocessing tools, Professor Middelberg and his team are developing vaccines that can be changed and manufactured for the entire Australian population within days of a appearing.

"The new vaccines we are developing are also much cheaper to mass-produce than traditional technologies, so are relevant where cost is an issue – for example, in the ," Professor Middelberg said.

"We use biotechnology to create the safe parts of a virus, and then we use nanotechnology to assemble these building blocks into a virus-like particle (VLP) in a reactor.

"VLPs resemble viruses but, as they only use the safe part of the virus, they are not infectious.

"However, being a safe mimic of the dangerous virus, they raise an excellent .

"Biotechnology allows us to make VLPs rapidly using bacteria, and the VLPs can be manipulated within reactors (not cells) to change composition and the new disease-causing agent.

"This enables an incredibly fast response to new threats."

Professor Middelberg said vaccines needed to be affordable.

"They need to be quickly mass produced once we identify a mutated or new virus – and certainly before it causes widespread disease," he said.

Current are made using egg-based technologies first developed in the 1930s.

"If we are surprised by a sudden change, as with in 2009, people die while they wait for the vaccine composition to 'catch up' with the new virus,"
Professor Middelberg said.

"This issue of speed is also critical for other new and emerging viruses that may invade from overseas, or even locally.

"We simply can't make vaccines fast enough.

"Such radical re-engineering of the system we use to make and deliver new vaccines will have a huge impact on how we can prevent disease, particularly in developing countries, and will bolster another old saying, 'prevention is better than cure'."

add to favorites email to friend print save as pdf

Related Stories

Novel pandemic flu vaccine effective against H5N1 in mice

Mar 01, 2009

Vaccines against H5N1 influenza will be critical in countering a possible future pandemic. Yet public health experts agree that the current method of growing seasonal influenza vaccines in chicken eggs is slow and inefficient.

Recommended for you

Growing a blood vessel in a week

14 hours ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

17 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

Oct 23, 2014

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments